Site Editor

Karl D. Lewis, MD

Advertisement

Advertisement

Videos

Steven M. Horwitz, MD, on PTCL and CTCL: Trial Results on Cerdulatinib, a Dual SYK/JAK Inhibitor

News

AACR 2021: Is Pembrolizumab Effective in Treating Advanced Cutaneous Squamous Cell Carcinoma?

Medical Literature

Vismodegib Therapy and Xanthomatous Dermal Changes: Case Study in Basal Cell Carcinoma

News

Long-Term Risk of Cutaneous Squamous Cell Carcinoma After Actinic Keratosis

Medical Literature

Non-Melanoma Skin Cancer Incidence and Chronic Occupational Radiation Exposure

News

Australian Surveillance Program for Individuals at High Risk of Aggressive Skin Cancer

Medical Literature

Are HCTZ-Containing Products Associated With Increased Risk of Non-Melanoma Skin Cancers?

Michael K.K. Wong, MD, PhD, on KRT-232: First-in-Class Agent for Merkel Cell Carcinoma

Karl D. Lewis, MD, on Selecting Patients for Treatment With Cemiplimab-rwlc

View More

Advertisement

JNCCN Spotlights

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

(UPDATE) Cemiplimab in Cutaneous Squamous Cell Carcinoma

View More

More

News

Sonidegib in Basal Cell Carcinoma: Half the Dose, Equal Results, Better Toxicity?

Long-Term Results With Vismodegib in Advanced Basal Cell Carcinoma: From The Netherlands

Follow-up Care Strategy for Patients With Low-Risk Basal Cell Carcinoma

Australian Surveillance Program for Individuals at High Risk of Aggressive Skin Cancer

Long-Term Risk of Cutaneous Squamous Cell Carcinoma After Actinic Keratosis

Postoperative Radiotherapy for Residual Disease in Cutaneous Squamous Cell Carcinoma

Delayed Diagnosis and Care of Skin Cancers in the Era of COVID-19

Novel Gene-Sequencing Approach to Identifying Non-Melanoma Carcinoma Risk

View More

Advertisement

Published

Medical Literature

9-Valent HPV Vaccine in Managing Squamous Cell Carcinoma: Case Report

miR-375 in Merkel Cell Carcinoma: An Intracellular Oncogene?

Is Parkinson’s Disease Associated With Development of Skin Cancer?

Could Non-Melanoma Skin Cancer Be Linked to Exfoliation Glaucoma?

View More

Ongoing

CE Activities

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

Dana-Farber Cancer Institute

Duke Cancer Institute

View More

Resources

For Your Patients

American Academy of Dermatology

Cancer<em>Care</em>

The Skin Cancer Foundation

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.